Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease

Lancet

Volumn 356, Issue 9230, 2000, Pages 610-612

  Armstrong, D ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADVERSE DRUG REACTION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; MAINTENANCE THERAPY; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0034686967     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02598-8     Document Type: Note

References (15)

1. EC Klinkenberg-Knol F Neils J Dent P Snel B Mitchell Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa Gastroenterology 118 2000 661 669
2. L Lundell J Dalenbäck J Hattlebakk Omeprazole or antireflux surgery in the long-term management of gastroesophageal reflux disease: results of a multicentre, randomized clinical trial (abstr) Gastroenterology 114 1998 A207
3. T Lind T Havelund L Lundell On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis: a placebo-controlled randomized trial Aliment Pharmacol Ther 13 1999 907 914
4. J Lagergren R Bergstrom A Lindgren O Nyren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831
5. EJ Kuipers L Lundell EC Klinkenberg-Knol Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication N Engl J Med 334 1996
6. L Lundell P Miettinen HE Myrvold Lack of effect of acid suppression on gastric atrophy Gastroenterology 117 1999 319 326
7. N Havu Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion Digestion 35 suppl 1986 42 55
8. L Laine D Ahnen C McClain E Solcia JH Walsh Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors Aliment Pharmacol Therap 14 2000 651 668
9. F Viani HH Siegrist B Pignatelli The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach Eur J Gastroenterol Hepatol 12 2000 165 173
10. Rodriguez LA Garcia A Ruigomez Gastric acid, acid-suppressing drugs and bacterial gastroenteritis. How much of a risk? Epidemiol 8 1997 571 574
11. EJ Kuipers SGM Meuwissen The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease Gastroenterology 118 2000 795 801
12. M Stolte A Meining E Seifert T Alexandridis Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach Pathol Res Pract 196 2000 9 13
13. U Choudhry HW Boyce Jr D Coppola Proton-pump-inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic and ultrastructural characteristics Am J Clin Pathol 110 1998 569 571
14. S Joelson IB Joelson P Lundborg A Walan MA Wallander Safety experience from long-term treatment with omeprazole Digestion 51 suppl 1 1992 93 101
15. JW Freston PA Rose CA Heller M Haber D Jennings Safety profile of lansoprazole: the US clinical trial experience Drug Safety 20 1999 195 205